GMDAQ — Gamida Cell Share News
0.000.00%
Last trade - 00:00- $2.62m
- $35.61m
- $1.78m
Brief: Gamida Cell Provides Regulatory Update On Omidubicel
Gamida Cell Ltd reports results for the quarter ended in September - Earnings Summary
Brief: Gamida Cell Reports Third Quarter 2022 Financial Results
Gamida Cell Ltd expected to post a loss of 31 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-EV stocks, Sarepta, Senti Biosciences
U.S. STOCKS ON THE MOVE-Peloton, Rivian, Proterra, Gamida
Gamida rises on positive data from blood cancer therapy study
Brief: Gamida Cell Says Long-Term Data From Omidubicel Phase 3 Trial Shows Certain Promising Outcomes For Patients With Blood Cancers At The Society Of Hematologic Oncology Meeting
U.S. STOCKS ON THE MOVE-Heartbeam, Aura Biosciences, U.S. banks
U.S. STOCKS ON THE MOVE-Airlines, Thor Industries, TCR2 Therapeutics
U.S. STOCKS ON THE MOVE-Biogen, Apple, Ocugen, Beauty Health
Gamida Cell slides on pricing $20 mln share offering
Brief: Gamida Cell Announces Pricing Of Approximately $20 Mln Public Offering Of Ordinary Shares
Brief: Gamida Cell Ltd Entered Into Commitment Letter With Highbridge Tactical Credit Master Fund, L.P.
Brief: Gamida Cell Announces Launch Of Public Offering Of Ordinary Shares
Brief: Gamida Cell Appoints Abigail Jenkins As President And CEO
Gamida Cell Ltd reports results for the quarter ended in June - Earnings Summary
Brief: Gamida Cell Reports Q2 2022 Financial Results
Gamida Cell Ltd expected to post a loss of 29 cents a share - Earnings Preview